Skip to content

New integrase inhibitor GSK1265744 safe and well tolerated in eight studies

Stribild is effective and well tolerated in older people with HIV

Joel Gallant, from the Southwest Care Center in Santa Fe, speaking at ICAAC 2013.

Single-tablet regimen improves antiretroviral adherence and reduces hospitalisation

Scott Sutton, from the Dorn Veterans Administration Medical Center and the University of South Carolina, speaking at ICAAC 2013.

Switching from Atripla to Eviplera reduces central nervous system side-effects

"If I am given antiretrovirals I will think I am nearing the grave" – a challenge for early treatment strategies

Raltegravir appears safe for mothers and babies during pregnancy

Vincen Jeantils speaking at ICAAC 2013.

Novel NNRTI AIC292 works well against drug-resistant HIV

Holger Zimmerman of AiCuris. Photo by Liz Highleyman, hivandhepatitis.com.

New NNRTI MK-1439 interacts with ritonavir but not tenofovir

Matt Anderson of Merck (speaking) with moderators Joseph Eron and Pablo Tebas (seated). Photo by Liz Highleyman, hivandhepatitis.com.

Dolutegravir shows good efficacy across broad range of patient groups

Judith Feinberg of the University of Cincinnati. Photo by Liz Highleyman, hivandhepatitis.com.